Trump expected to sign order reclassifying marijuana as a Schedule III drug, sources say

OG article by Aaron Navarro, Joe Walsh

December 18, 2025

President Trump is anticipated to sign an executive order on Thursday that would reclassify marijuana from a Schedule I drug to a Schedule III classification, according to two sources familiar with the matter. This change represents a major shift in federal drug policy. One source noted that the signing might not occur exactly on Thursday. Schedule I drugs, as defined by the Drug Enforcement Administration, include substances with no accepted medical use and high abuse potential, such as heroin, LSD, ecstasy, and currently marijuana. Schedule III covers items with moderate to low dependence potential, like Tylenol with codeine, testosterone, anabolic steroids, and ketamine. The rescheduling would keep marijuana illegal for recreational purposes federally but could enable more studies on its medical applications and broaden approved uses. It might also reduce tax obligations for cannabis dispensaries in states where the drug is legal, since federal rules prevent deductions for Schedule I businesses. Trump mentioned on Monday that he is weighing this move due to extensive research barriers. "Rescheduling will help accelerate research, reduce stigma, attract new investment, and ease some of the tax burdens that have held the industry back," stated Vince C. Ning, co-CEO of Nabis. CNN reported the order's planned timing. Trump expressed support for Schedule III during his campaign and last year. The prior administration's Health and Human Services suggested the downgrade, and the Justice Department proposed it, though delays persisted. Marijuana has held Schedule I status since 1970. Most states now permit medical use, and 24 allow recreational, conflicting with federal law but without enforcement. Bipartisan support exists for relaxed rules, citing benefits and public approval. Trump advocated ending arrests for small amounts and ensuring safe access. However, 22 Republican senators urged maintaining Schedule I, citing health risks,

driving impairment, and economic concerns. Nine House Republicans similarly opposed, claiming insufficient data and potential abuse. The White House has been contacted for comment.